Hypofractionated Radiotherapy and Concurrent Cisplatin for Head and Neck Cancer

• Status: Unknown status
• Trial end date: 2019-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate the feasibility of hypofractionated radiation therapy and concomitant chemotherapy with cisplatin for locally advanced head and neck cancer in a high volume brazilian center.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Barretos Cancer Hospital
• Treatments: Cisplatin

Criteria

Inclusion Criteria:

• Biopsy proven squamous cell carcinoma of oropharynx, larynx and hypopharynx.

• Stage III an IV, with no distant metastasis.

• ECOG performance status 0-2.

• Adequate renal and liver function.

• Good status for radical treatment

Exclusion Criteria:

• Other oncologic treatment before

• Distant metastasis

• History of previous malignancy